Weiwei Lai

2.3k total citations · 2 hit papers
28 papers, 1.6k citations indexed

About

Weiwei Lai is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Weiwei Lai has authored 28 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 14 papers in Cancer Research and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Weiwei Lai's work include RNA modifications and cancer (12 papers), Cancer-related molecular mechanisms research (10 papers) and Epigenetics and DNA Methylation (6 papers). Weiwei Lai is often cited by papers focused on RNA modifications and cancer (12 papers), Cancer-related molecular mechanisms research (10 papers) and Epigenetics and DNA Methylation (6 papers). Weiwei Lai collaborates with scholars based in China, Saudi Arabia and United States. Weiwei Lai's co-authors include Yongguang Tao, Ya Cao, Desheng Xiao, Chao Mao, Yating Liu, Hu Zhou, Min Wang, Shuang Liu, Yiqun Jiang and Bin Yan and has published in prestigious journals such as Cancer Research, Oncogene and International Journal of Molecular Sciences.

In The Last Decade

Weiwei Lai

26 papers receiving 1.6k citations

Hit Papers

Long noncoding RNA LINC00336 inhibits ferroptosis in lung... 2018 2026 2020 2023 2019 2018 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weiwei Lai China 16 1.2k 1.1k 822 121 63 28 1.6k
Feimei Kuang China 8 1.1k 0.9× 880 0.8× 1.2k 1.4× 176 1.5× 160 2.5× 10 1.7k
Stefania Perdichizzi Italy 19 596 0.5× 267 0.2× 454 0.6× 254 2.1× 99 1.6× 26 1.2k
Pan Chen China 8 456 0.4× 360 0.3× 468 0.6× 64 0.5× 36 0.6× 10 736
Jiandang Shi China 23 606 0.5× 252 0.2× 243 0.3× 184 1.5× 94 1.5× 52 1.1k
Lianlian Ouyang China 14 834 0.7× 687 0.6× 527 0.6× 93 0.8× 99 1.6× 25 1.1k
Zhi Ji China 11 714 0.6× 583 0.5× 448 0.5× 257 2.1× 106 1.7× 29 1.1k
Marcin Braun Poland 13 568 0.5× 296 0.3× 225 0.3× 297 2.5× 68 1.1× 88 1.1k
Amy Tarangelo United States 7 1000 0.8× 893 0.8× 1.0k 1.2× 176 1.5× 62 1.0× 9 1.4k

Countries citing papers authored by Weiwei Lai

Since Specialization
Citations

This map shows the geographic impact of Weiwei Lai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiwei Lai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiwei Lai more than expected).

Fields of papers citing papers by Weiwei Lai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiwei Lai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiwei Lai. The network helps show where Weiwei Lai may publish in the future.

Co-authorship network of co-authors of Weiwei Lai

This figure shows the co-authorship network connecting the top 25 collaborators of Weiwei Lai. A scholar is included among the top collaborators of Weiwei Lai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiwei Lai. Weiwei Lai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gao, Yuan, Mengxia Zhang, Weiwei Lai, et al.. (2025). Metabolic cross-talk between glioblastoma and glioblastoma-associated microglia/macrophages: From basic insights to therapeutic strategies. Critical Reviews in Oncology/Hematology. 208. 104649–104649. 4 indexed citations
2.
Lai, Weiwei, Li Liu, Shuhang Wang, Yancun Liu, & Yanfen Chai. (2025). Integrated Omics Insights into Dapagliflozin Effects in Sepsis-Induced Cardiomyopathy. Biomolecules. 15(2). 286–286. 3 indexed citations
3.
Guo, Jiaxing, et al.. (2025). GPR34 Stabilized by Deubiquitinase USP8 Suppresses Ferroptosis of ATC. Mediators of Inflammation. 2025(1). 5576056–5576056.
4.
Lai, Weiwei, et al.. (2025). The impact of diabetes on Sepsis-induced cardiomyopathy. Diabetes Research and Clinical Practice. 220. 112001–112001. 3 indexed citations
5.
Lai, Weiwei, et al.. (2024). Antitumor activity of Polygonatum sibiricum polysaccharides. Archives of Pharmacal Research. 47(8-9). 696–708. 13 indexed citations
6.
Long, Yao, Jiaxing Guo, Jielin Chen, et al.. (2023). GPR162 activates STING dependent DNA damage pathway as a novel tumor suppressor and radiation sensitizer. Signal Transduction and Targeted Therapy. 8(1). 48–48. 29 indexed citations
7.
Ouyang, Lianlian, Yangying Zhou, Weiwei Lai, et al.. (2023). AhR Promotes the Development of Non-small cell lung cancer by Inducing SLC7A11-dependent Antioxidant Function. Journal of Cancer. 14(5). 821–834. 24 indexed citations
8.
Liu, Yating, Lianlian Ouyang, Chao Mao, et al.. (2022). PCDHB14 promotes ferroptosis and is a novel tumor suppressor in hepatocellular carcinoma. Oncogene. 41(27). 3570–3583. 47 indexed citations
9.
Liu, Shouping, Weiwei Lai, Ying Shi, et al.. (2020). Annotation and cluster analysis of long noncoding RNA linked to male sex and estrogen in cancers. npj Precision Oncology. 4(1). 5–5. 13 indexed citations
10.
Liu, Na, Rui Yang, Yongyong Shi, et al.. (2020). The cross-talk between methylation and phosphorylation in lymphoid-specific helicase drives cancer stem-like properties. Signal Transduction and Targeted Therapy. 5(1). 197–197. 24 indexed citations
11.
Wang, Min, Chao Mao, Lianlian Ouyang, et al.. (2019). Long noncoding RNA LINC00336 inhibits ferroptosis in lung cancer by functioning as a competing endogenous RNA. Cell Death and Differentiation. 26(11). 2329–2343. 429 indexed citations breakdown →
12.
Wang, Min, Chao Mao, Lianlian Ouyang, et al.. (2019). Correction to: Long noncoding RNA LINC00336 inhibits ferroptosis in lung cancer by functioning as a competing endogenous RNA. Cell Death and Differentiation. 27(4). 1447–1447. 26 indexed citations
13.
Yang, Rui, Na Liu, Ling Chen, et al.. (2019). LSH interacts with and stabilizes GINS4 transcript that promotes tumourigenesis in non-small cell lung cancer. Journal of Experimental & Clinical Cancer Research. 38(1). 280–280. 41 indexed citations
14.
Mao, Chao, Xiang Wang, Yating Liu, et al.. (2018). A G3BP1-Interacting lncRNA Promotes Ferroptosis and Apoptosis in Cancer via Nuclear Sequestration of p53. Cancer Research. 78(13). 3484–3496. 402 indexed citations breakdown →
15.
Shi, Yongyong, Na Liu, Weiwei Lai, et al.. (2018). Nuclear EGFR-PKM2 axis induces cancer stem cell-like characteristics in irradiation-resistant cells. Cancer Letters. 422. 81–93. 37 indexed citations
16.
Jia, Jiantao, Yongyong Shi, Ling Chen, et al.. (2017). Decrease in Lymphoid Specific Helicase and 5-hydroxymethylcytosine Is Associated with Metastasis and Genome Instability. Theranostics. 7(16). 3920–3932. 44 indexed citations
17.
Lai, Weiwei, Jiantao Jia, Bin Yan, et al.. (2017). Baicalin hydrate inhibits cancer progression in nasopharyngeal carcinoma by affecting genome instability and splicing. Oncotarget. 9(1). 901–914. 33 indexed citations
18.
Jiang, Yiqun, Chao Mao, Rui Yang, et al.. (2017). EGLN1/c-Myc Induced Lymphoid-Specific Helicase Inhibits Ferroptosis through Lipid Metabolic Gene Expression Changes. Theranostics. 7(13). 3293–3305. 233 indexed citations
19.
Jia, Jiantao, Yongyong Shi, Bin Yan, et al.. (2016). LGR5 expression is controled by IKKα in basal cell carcinoma through activating STAT3 signaling pathway. Oncotarget. 7(19). 27280–27294. 23 indexed citations
20.
Liu, Shuang, Bin Yan, Weiwei Lai, et al.. (2014). As a novel p53 direct target, bidirectional gene HspB2/αB-crystallin regulates the ROS level and Warburg effect. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms. 1839(7). 592–603. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026